127 related articles for article (PubMed ID: 10225963)
1. Finally, CTLA4Ig graduates to the clinic.
Sayegh MH
J Clin Invest; 1999 May; 103(9):1223-5. PubMed ID: 10225963
[No Abstract] [Full Text] [Related]
2. Review of CTLA4Ig use for allograft immunosuppression.
Lin H; Wei RQ; Gordon D; Linsley P; Turka LA; Bolling SF
Transplant Proc; 1994 Dec; 26(6):3200-1. PubMed ID: 7998114
[No Abstract] [Full Text] [Related]
3. CTLA-4: new insights into its biological function and use in tumor immunotherapy.
Egen JG; Kuhns MS; Allison JP
Nat Immunol; 2002 Jul; 3(7):611-8. PubMed ID: 12087419
[TBL] [Abstract][Full Text] [Related]
4. The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease.
Green JM
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):261-4. PubMed ID: 10696061
[No Abstract] [Full Text] [Related]
5. The CD28 and CTLA-4 receptor family.
June CH; Vandenberghe P; Thompson CB
Chem Immunol; 1994; 59():62-90. PubMed ID: 7945930
[No Abstract] [Full Text] [Related]
6. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.
Abrams JR; Lebwohl MG; Guzzo CA; Jegasothy BV; Goldfarb MT; Goffe BS; Menter A; Lowe NJ; Krueger G; Brown MJ; Weiner RS; Birkhofer MJ; Warner GL; Berry KK; Linsley PS; Krueger JG; Ochs HD; Kelley SL; Kang S
J Clin Invest; 1999 May; 103(9):1243-52. PubMed ID: 10225967
[TBL] [Abstract][Full Text] [Related]
7. Local immunomodulation to promote co-stimulatory blockade.
Chahine AA; Stoeckert C; Lau HT
Clin Transplant; 1995 Jun; 9(3 Pt 2):215-8. PubMed ID: 7670166
[No Abstract] [Full Text] [Related]
8. T cell activation: you can't get good help.
Linsley PS
Nat Immunol; 2001 Feb; 2(2):139-40. PubMed ID: 11175808
[No Abstract] [Full Text] [Related]
9. CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus.
Mihara M; Tan I; Chuzhin Y; Reddy B; Budhai L; Holzer A; Gu Y; Davidson A
J Clin Invest; 2000 Jul; 106(1):91-101. PubMed ID: 10880052
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis.
McIntosh KR; Linsley PS; Drachman DB
Cell Immunol; 1995 Nov; 166(1):103-12. PubMed ID: 7585970
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to CTLA-4 enhance T cell proliferation.
Matsui T; Nishioka K; Kato T; Yamamoto K
J Rheumatol; 2001 Jan; 28(1):220-1. PubMed ID: 11196536
[No Abstract] [Full Text] [Related]
12. Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis.
Nishikawa K; Linsley PS; Collins AB; Stamenkovic I; McCluskey RT; Andres G
Eur J Immunol; 1994 Jun; 24(6):1249-54. PubMed ID: 8206086
[TBL] [Abstract][Full Text] [Related]
13. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
[TBL] [Abstract][Full Text] [Related]
14. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
16. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma.
Padrid PA; Mathur M; Li X; Herrmann K; Qin Y; Cattamanchi A; Weinstock J; Elliott D; Sperling AI; Bluestone JA
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):453-62. PubMed ID: 9533932
[TBL] [Abstract][Full Text] [Related]
17. Intervention of CD4+ cell subset shifts and autoimmunity in the BXSB mouse by murine CTLA4Ig.
Chu EB; Hobbs MV; Wilson CB; Romball CG; Linsley PS; Weigle WO
J Immunol; 1996 Feb; 156(3):1262-8. PubMed ID: 8558006
[TBL] [Abstract][Full Text] [Related]
18. CTLA4Ig-induced linked regulation of allogeneic T cell responses.
Lee RS; Rusche JR; Maloney ME; Sachs DH; Sayegh MH; Madsen JC
Transplant Proc; 2001; 33(1-2):88-9. PubMed ID: 11266718
[No Abstract] [Full Text] [Related]
19. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
Jooss K; Turka LA; Wilson JM
Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
[TBL] [Abstract][Full Text] [Related]
20. T-cell regulation by CD28 and CTLA-4.
Alegre ML; Frauwirth KA; Thompson CB
Nat Rev Immunol; 2001 Dec; 1(3):220-8. PubMed ID: 11905831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
